Personal information

Other IDs

Scopus Author ID: 54879940200

Activities

Collapse all

Works (23)

Thiazole – A promising scaffold for antituberculosis agents and structure–activity relationships studies

Bioorganic Chemistry
2025 | Journal article
DOI: 10.1016/j.bioorg.2024.108035
EID:

2-s2.0-85212319359

Part of ISSN: 10902120 00452068
Contributors: Zhao, X.; Di, J.; Luo, D.; Verma, R.; Verma, S.K.; Verma, S.; Ravindar, L.; Koshle, A.; Dewangan, H.K.; Gupta, R. et al.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

Azole and chlorine: An effective combination in battle against methicillin-resistance staphylococcus aureus (MRSA) and its SAR studies

Journal of Molecular Structure
2024 | Journal article
DOI: 10.1016/j.molstruc.2023.137283
EID:

2-s2.0-85180367254

Part of ISSN: 00222860
Contributors: Verma, R.; Verma, S.K.; Verma, S.; Vaishnav, Y.; Banjare, L.; Yadav, R.; Sridhara, M.B.; Rakesh, K.P.; Sharath Kumar, K.S.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

Exploring novel Apalutamide analogues as potential therapeutics for prostate cancer: design, molecular docking investigations and molecular dynamics simulation

Frontiers in Chemistry
2024 | Journal article
DOI: 10.3389/fchem.2024.1418975
EID:

2-s2.0-85201536012

Part of ISSN: 22962646
Contributors: Gupta, A.K.; Vaishnav, Y.; Jain, S.K.; Annadurai, S.; Kumar, N.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

Recent developments of P-glycoprotein inhibitors and its structure–activity relationship (SAR) studies

Bioorganic Chemistry
2024 | Journal article
DOI: 10.1016/j.bioorg.2023.106997
EID:

2-s2.0-85178386035

Part of ISSN: 10902120 00452068
Contributors: Zhao, X.; Di, J.; Luo, D.; Vaishnav, Y.; Kamal; Nuralieva, N.; Verma, D.; Verma, P.; Verma, S.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

2D & 3D-QSAR Studies on a Series of Quinoline-Aminopiperidine Derivatives as Potent Mycobacterium DNA-Gyrase-B Inhibitors

International Journal of Pharmaceutical Sciences and Nanotechnology
2023 | Journal article
DOI: 10.37285/ijpsn.2023.16.3.5
EID:

2-s2.0-85168125651

Part of ISSN: 09743278
Contributors: Pandit, B.; Vaishnav, Y.; Bahadur, S.; Satapathy, T.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

Aminoquinoline Analogues as Potent Inhibitors of Mycobacterial DNA-GyraseB: 2D and 3D-QSAR Studies

Indian Journal of Heterocyclic Chemistry
2023 | Journal article
DOI: 10.59467/ijhc.2023.33.127
EID:

2-s2.0-85168839967

Part of ISSN: 24564311 09711627
Contributors: Pandit, B.; Vaishnav, Y.; Bahadur, S.; Satapathy, T.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

Development of Pharmacovigilance System in India and Paradigm of Pharmacovigilance Research: An Overview

Current Drug Safety
2023 | Journal article
DOI: 10.2174/1574886317666220930145603
EID:

2-s2.0-85147276348

Part of ISSN: 22123911 15748863
Contributors: Singh, P.; Vaishnav, Y.; Verma, S.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier
grade
Preferred source (of 2)‎

Point of Care diagnostics - Using Nanomaterials as detection probes

Research Journal of Pharmacy and Technology
2023 | Journal article
DOI: 10.52711/0974-360X.2023.00575
EID:

2-s2.0-85178932629

Part of ISSN: 0974360X 09743618
Contributors: Yadav, R.; Vaishnav, Y.; Verma, S.; Kaur, A.; Manjunath, K.; Pandey, A.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

Regioselective Synthesis, Antiproliferative Effect and Molecular Docking Studies of 2,3,5-Tri(Het)Aryl-Pyrrole Derivatives as a New Inhibitor of JAK3, VEGFR and PARP

SSRN
2023 | Other
DOI: 10.2139/ssrn.4380100
EID:

2-s2.0-85150709875

Part of ISSN: 15565068
Contributors: Verma, R.; Verma, S.; Hamse, V.K.; Vaishnav, Y.; Saji, J.; Verma, S.K.; Sharath Kumar, K.S.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

Two-dimensional Ti<sub>3</sub>C<sub>2</sub>T<sub>x</sub> MXenes as a catalyst support for the synthesis of 1,4-disubstituted-1,2,3-triazoles via azide-nitroalkene oxidative cycloaddition

Journal of Molecular Structure
2023 | Journal article
DOI: 10.1016/j.molstruc.2023.135145
EID:

2-s2.0-85148545324

Part of ISSN: 00222860
Contributors: Verma, S.K.; Verma, R.; Girish, Y.R.; Verma, S.; Pramoda, K.; Vaishnav, Y.; Saji, J.; Kumar, K.S.S.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

Computational Method on Hydroxychloroquine and Azithromycin for SARS-CoV-2: Binding Affinity Studies

Research Journal of Pharmacy and Technology
2022 | Journal article
DOI: 10.52711/0974-360X.2022.00922
EID:

2-s2.0-85146215726

Part of ISSN: 0974360X 09743618
Contributors: Vaishnav, Y.; Banjare, L.; Verma, S.; Sharma, G.; Biswas, D.; Tripathi, A.; Shaik, A.B.; Bhandare, R.R.; Kaur, A.; Manjunath, K.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

Erratum: Heterogeneous graphitic carbon nitrides in visible-light-initiated organic transformations (Green Chemistry (2022)DOI: 10.1039/d1gc03490a)

Green Chemistry
2022 | Journal article
DOI: 10.1039/d2gc90005j
EID:

2-s2.0-85123958119

Part of ISSN: 14639270 14639262
Contributors: Verma, S.K.; Verma, R.; Girish, Y.R.; Xue, F.; Yan, L.; Verma, S.; Singh, M.; Vaishnav, Y.; Shaik, A.B.; Bhandare, R.R. et al.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

Formulation and In-vitro evaluation of electrolyte effervescent tablet

Journal of Medical Pharmaceutical and Allied Sciences
2022 | Journal article
DOI: 10.22270/jmpas.V11I1.2303
EID:

2-s2.0-85126579594

Part of ISSN: 23207418
Contributors: Tripathi, A.K.; Vaishnav, Y.; Sonker, I.; Ahirwar, K.; Pandey, A.K.; Verma, S.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

Heterogeneous graphitic carbon nitrides in visible-light-initiated organic transformations

Green Chemistry
2022 | Journal article
DOI: 10.1039/d1gc03490a
EID:

2-s2.0-85123721260

Part of ISSN: 14639270 14639262
Contributors: Verma, S.K.; Verma, R.; Girish, Y.R.; Xue, F.; Yan, L.; Verma, S.; Singh, M.; Vaishnav, Y.; Shaik, A.B.; Bhandare, R.R. et al.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

Multistep synthesis and screening of heterocyclic tetrads containing furan, pyrazoline, thiazole and triazole (or oxadiazole) as antimicrobial and anticancer agents

Journal of Saudi Chemical Society
2022 | Journal article
DOI: 10.1016/j.jscs.2022.101447
EID:

2-s2.0-85126126012

Part of ISSN: 13196103
Contributors: Bhandare, R.R.; S.Munikrishnappa, C.; Suresh Kumar, G.V.; Konidala, S.K.; Sigalapalli, D.K.; Vaishnav, Y.; Chinnam, S.; Yasin, H.; Al-karmalawy, A.A.; Shaik, A.B.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

3D QSAR analysis on quinoxaline derivatives as anti-malarial using K-nearest neighbour molecular field analysis

Indian Journal of Chemistry - Section B Organic and Medicinal Chemistry
2021 | Journal article
EID:

2-s2.0-85115408476

Part of ISSN: 03764699
Contributors: Mishra, A.; Vaishnav, Y.; Jha, A.K.; Verma, S.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

Anti-tuberculosis activity and its structure-activity relationship (SAR) studies of oxadiazole derivatives: A key review

European Journal of Medicinal Chemistry
2021 | Journal article
DOI: 10.1016/j.ejmech.2020.112886
EID:

2-s2.0-85092100138

Part of ISSN: 17683254 02235234
Contributors: Verma, S.K.; Verma, R.; Verma, S.; Vaishnav, Y.; Tiwari, S.P.; Rakesh, K.P.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

Catalytic pyrolysis of ulva lactuca macroalgae: Effects of mono and bimetallic catalysts and reaction parameters on bio-oil up-gradation

Bioresource Technology
2021 | Journal article
DOI: 10.1016/j.biortech.2020.124594
EID:

2-s2.0-85099215879

Part of ISSN: 18732976 09608524
Contributors: Verma, R.; Verma, S.K.; Verma, V.; Verma, S.; Vaishnav, Y.; Jena, V.; Kumar, A.; Rakesh, K.P.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

Synthesis, molecular docking, and biological evaluation of Schiff base hybrids of 1,2,4-triazole-pyridine as dihydrofolate reductase inhibitors

Current Research in Pharmacology and Drug Discovery
2021 | Journal article
DOI: 10.1016/j.crphar.2021.100024
EID:

2-s2.0-85125604645

Part of ISSN: 25902571
Contributors: Dewangan, D.; Vaishnav, Y.; Mishra, A.; Jha, A.K.; Verma, S.; Badwaik, H.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

PPAR gamma targeted molecular docking and synthesis of some new amide and urea substituted 1, 3, 4-thiadiazole derivative as antidiabetic compound

Journal of Heterocyclic Chemistry
2020 | Journal article
DOI: 10.1002/jhet.3941
EID:

2-s2.0-85080910751

Part of ISSN: 19435193 0022152X
Contributors: Vaishnav, Y.; Dewangan, D.; Verma, S.; Mishra, A.; Thakur, A.S.; Kashyap, P.; Verma, S.K.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier
grade
Preferred source (of 2)‎

Qsar analysis of some N, N-diphenyl urea derivatives as CCR5 receptor antagonist

Research Journal of Pharmacy and Technology
2018 | Journal article
DOI: 10.5958/0974-360X.2018.00697.2
EID:

2-s2.0-85079662925

Part of ISSN: 0974360X 09743618
Contributors: Vaishnav, Y.; Thakur, A.; Kaur, C.D.; Verma, S.; Mishra, A.; Jain, S.K.; Ghode, P.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

An approach to design potent anti diabetic agents by 3D QSAR studies on substituted thiadiazole derivatives using kNN -MFA methodology

Indian Journal of Heterocyclic Chemistry
2016 | Journal article
EID:

2-s2.0-85059914426

Part of ISSN: 09711627
Contributors: Vaishnav, Y.; Kashyap, P.; Kaur, C.D.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

Synthesis of some novel 4-(4-chlorophenyl)-6-p-tolyl-+-pyrimidine derivatives and their anticonvulsant activity

Acta Poloniae Pharmaceutica - Drug Research
2011 | Journal article
EID:

2-s2.0-84855166685

Part of ISSN: 00016837
Contributors: Thakur, D.S.; Rajak, H.; Kumar, P.; Vaishnav, Y.
Source: Self-asserted source
Yogesh Vaishnav via Scopus - Elsevier

Peer review (1 review for 1 publication/grant)

Review activity for Chemistry & biodiversity. (1)
How many people are using ORCID?